Comparison of Immune Response in Mice Immunized with Recombinant PreS2/S-C18-27 Protein Derived from Hepatitis B Virus with Commercial Vaccine
The vaccine available to prevent Hepatitis B virus disease is ineffective in 5% of people due to the use of HBsAg as a weak immunogenic factor. In the present study, PreS2/S fused to C18-27 peptide fragment as an effective antigen and is proposed as a promising vaccine candidate compared with the co...
Saved in:
Published in | Iranian journal of pathology Vol. 17; no. 4; pp. 448 - 460 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Iran
2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!